Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic Cancer (Q36067677)
scientific article published on May 1, 2013
Language:
(P31) (Q13442814)
(P304) 83-90
(P407) (Q1860)
(P433) 1
(P478) 86
(P577) Wednesday, May 1, 2013
(P953) https://europepmc.org/articles/pmc4572833?pdf=render
https://europepmc.org/articles/PMC4572833
https://europepmc.org/articles/PMC4572833?pdf=render
https://doi.org/10.1016/j.ijrobp.2013.01.017
https://api.elsevier.com/content/article/PII:S0360301613000813?httpAccept=text/xml
https://api.elsevier.com/content/article/PII:S0360301613000813?httpAccept=text/plain
(P1433) (Q2296252)
(P1476) "Hematologic toxicity in RTOG 0418: a phase 2 study of postoperative IMRT for gynecologic cancer" (language: en)
"Hematologic Toxicity in RTOG 0418: A Phase 2 Study of Postoperative IMRT for Gynecologic Cancer" (language: en)
(P2093) Jennifer Moughan
Lorraine Portelance
Evangeline Hildebrandt
Jenny Nuanjing
David D'Souza
Luis Souhami
William Small
Rakesh Gaur
Anuja Jhingran
Ann H. Klopp
Brigitte E. Miller
Mohammad R. Salehpour
(P2860) (Q34534085)
(Q37806149)
(Q37753408)
(Q34009168)
(Q33377344)
(Q33371450)
(Q44296363)
(Q81363673)
(Q84227409)
(Q83737796)
(Q73675166)
(Q77639619)
(Q63199182)
(Q63199190)
other details
description scientific article published on May 1, 2013

External Links